SCR-LIP-000633 · Claim · machine-readable JSON →

Lipedema subcutaneous tissue shows increased immune cell infiltration, predominantly macrophages, compared with matched controls.

General proposition consolidated from 6 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
moderate (GRADE)
Evidence
6 source(s)
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20192026Dilated Blood and Lymphatic Microvessels, Angiogenesis, Increased Macrophages, and Adipocyte Hypertrophy in Lipedema Thigh Skin and Fat Tissue — AL-Ghadban et al. (2019) · consistentLipedema: A Painful Adipose Tissue Disorder — Al-Ghadban et al. (2019) · consistentIncreased levels of VEGF-C and macrophage infiltration in lipedema patients without changes in lymphatic vascular morphology — Felmerer et al. (2020) · consistentInvolvement of the Macrophage Migration Inhibitory Factor (MIF) in Lipedema — Vasella et al. (2023) · refiningTargeting Mast Cells: Sodium Cromoglycate as a Possible Treatment of Lipedema — Bonetti G et al. (2023) · refiningThe Etiology of Pain in Lipedema Is Not Yet Fully Understood. An Integrative Synthesis of Inflammatory, Hypoxic-Hemorrhagic, Adipomyofascial, and Neuromolecular Mechanisms Based on Histopathological Evidences (2026) · consistent

Evidence (6)

Context (PECO)

Populationwomen with lipedema vs BMI-matched healthy controls
Conditionlipedema
Exposurelipedema tissue pathology
ComparatorBMI-matched healthy patient biopsies
Outcomeleukocyte infiltration, macrophage polarization, VEGF-C serum levels
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log